Select Publications
Book Chapters
, 2022, 'Infection of mother and baby', in Keeling S Fetal and Neonatal Pathology, pp. 207 - 245, http://dx.doi.org/10.1007/978-3-030-84168-3_9
, 2022, 'Neisseria meningitidis', in Molecular Typing in Bacterial Infections Volume I Second Edition, pp. 85 - 99, http://dx.doi.org/10.1007/978-3-030-74018-4_3
, 2018, 'The Impact of Infection During Pregnancy on the Mother and Baby', in Keeling S Fetal and Neonatal Pathology Fifth Edition, pp. 219 - 256, http://dx.doi.org/10.1007/978-3-319-19207-9_9
, 2015, 'Neisseria gonorrhoeae: The Pathogen, Diagnosis, and Antimicrobial Resistance', in Singh SK (ed.), Human Emerging and Re Emerging Infections Viral and Parasitic Infections Volume 2, pp. 683 - 697, http://dx.doi.org/10.1002/9781118644843.ch37
, 2015, 'The impact of infection during pregnancy on the mother and baby', in Keeling S Fetal and Neonatal Pathology, pp. 219 - 256, http://dx.doi.org/10.1007/978-3-319-19207-9_9
, 2007, 'The Impact of Infection During Pregnancy on the Mother and Baby', in Fetal and Neonatal Pathology, Springer Nature, pp. 379 - 423, http://dx.doi.org/10.1007/978-1-84628-743-5_16
Journal articles
, 2026, 'Australian Gonococcal Surveillance Program, 1 January to 31 March 2026', Communicable Diseases Intelligence, 50, http://dx.doi.org/10.33321/cdi.2026.50.060
, 2026, 'Australian Gonococcal Surveillance Programme Annual Report, 2025', Communicable Diseases Intelligence, 50, http://dx.doi.org/10.33321/cdi.2026.50.057
, 2026, 'Atypical infections caused by pathogenic Neisseria species N. meningitidis and N. gonorrhoeae.', Clinical Microbiology Reviews, pp. e0009126, http://dx.doi.org/10.1128/cmr.00091-26
, 2026, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2026', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.055
, 2026, 'A 14-Year-old Girl With Neurologic Decline and Unexpected CSF Findings', Pediatric Infectious Disease Journal, 45, http://dx.doi.org/10.1097/INF.0000000000005280
, 2026, 'Meningococcal B Vaccine to Prevent Neisseria gonorrhoeae Infection', New England Journal of Medicine, 395, pp. 349 - 361, http://dx.doi.org/10.1056/NEJMoa2516739
, 2026, 'False-positive Neisseria gonorrhoeae results on the Abbott Alinity m STI assay caused by Neisseria meningitidis: two cases from Australia', Journal of Clinical Microbiology, 64, http://dx.doi.org/10.1128/jcm.00347-26
, 2026, 'Neisseria meningitidis MenY ST-1466 harbouring Neisseria gonorrhoeae 16S rRNA allele causing false-positive Aptima® gonococcal nucleic acid amplification test results', Clinical Microbiology and Infection, 32, pp. 1187 - 1189, http://dx.doi.org/10.1016/j.cmi.2026.01.027
, 2026, 'Australian Gonococcal Surveillance Program, 1 October to 31 December 2025', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.035
, 2026, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2025', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.027
, 2026, 'Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2025', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.036
, 2026, 'Antimicrobial-Resistant Neisseria gonorrhoeae of Public Health Concern, New South Wales, Australia, 2022–2024', Emerging Infectious Diseases, 32, pp. 905 - 913, http://dx.doi.org/10.3201/eid3206.251399
, 2026, 'Limitations of Global Surveillance for Neisseria gonorrhoeae Antimicrobial Resistance', Emerging Infectious Diseases, 32, pp. 839 - 843, http://dx.doi.org/10.3201/eid3206.260378
, 2026, 'Australian Gonococcal Surveillance Program, 1 July to 30 September 2025', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.018
, 2026, 'Maternal vaginal colonisation with Neisseria meningitidis serogroup B and late onset neonatal invasive meningococcal disease', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.017
, 2026, 'Transport time, not transport method, predicts Neisseria gonorrhoeae culture yield in an urban setting', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.011
, 2026, 'Australian Gonococcal Surveillance Program, 1 April to 30 June 2025', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.005
, 2026, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2025', Communicable Diseases Intelligence 2018, 50, http://dx.doi.org/10.33321/cdi.2026.50.006
, 2026, 'High in vitro activity of the novel antimicrobial gepotidacin against Neisseria gonorrhoeae isolates in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021–24', Journal of Antimicrobial Chemotherapy, 81, pp. dkaf452, http://dx.doi.org/10.1093/jac/dkaf452
, 2026, 'Gene exchange between Neisseria meningitidis and Neisseria gonorrhoeae', Microbial Genomics, 12, http://dx.doi.org/10.1099/mgen.0.001623
, 2026, 'Surveillance of antimicrobial resistance by a global network of WHO collaborating centres', Bulletin of the World Health Organization, 104, pp. 259 - 273, http://dx.doi.org/10.2471/BLT.25.294384
, 2026, 'Centre-of-Research-Excellence in Neisseria Disease Control (NEIS CRE): Long-term 4CMenB effectiveness against Neisseria', Australian and New Zealand Journal of Public Health, 50, pp. 100432, http://dx.doi.org/10.1016/j.anzjph.2026.100432
, 2025, '2025 Review of Public Health Laboratory Network Australia Neisseria gonorrhoeae National Nucleic Acid Amplification Testing Guidelines', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.067
, 2025, 'Australian Gonococcal Surveillance Programme Annual Report, 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.056
, 2025, 'Australian Meningococcal Surveillance Programme Annual Report, 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.057
, 2025, 'Determining targets for ceftriaxone resistance detection in Neisseria gonorrhoeae based on genotype–phenotype data: an observational study', Lancet Microbe, 6, http://dx.doi.org/10.1016/j.lanmic.2025.101199
, 2025, 'Invasive Urogenital Neisseria meningitidis Serogroup Y Multilocus Sequence Type 1466', Emerging Infectious Diseases, 31, pp. 2067, http://dx.doi.org/10.3201/eid3110.250902
, 2025, 'The World Health Organization (WHO) Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) reports continuously high levels of ceftriaxone resistance across Viet Nam, 2024', Lancet Regional Health Western Pacific, 63, http://dx.doi.org/10.1016/j.lanwpc.2025.101709
, 2025, 'WHO global gonococcal antimicrobial surveillance programmes, 2019–22: a retrospective observational study', Lancet Microbe, 6, http://dx.doi.org/10.1016/j.lanmic.2025.101181
, 2025, 'Antimicrobial resistance in Neisseria gonorrhoeae in nine sentinel countries within the World Health Organization Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2023: a retrospective observational study', Lancet Regional Health Western Pacific, 61, http://dx.doi.org/10.1016/j.lanwpc.2025.101663
, 2025, 'Australian Gonococcal Surveillance Program, 1 October to 31 December 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.036
, 2025, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2025', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.045
, 2025, 'Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.039
, 2025, 'Exceedingly high levels of tetracycline resistance in Neisseria gonorrhoeae in eight WHO Enhanced Gonococcal Antimicrobial Surveillance Programme countries in three WHO regions, 2021–2024—doxycycline post-exposure prophylaxis will unlikely impact gonorrhoea burdens', Journal of Antimicrobial Chemotherapy, 80, pp. 1291 - 1295, http://dx.doi.org/10.1093/jac/dkaf066
, 2025, 'Australian Gonococcal Surveillance Programme, 1 July to 30 September 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.018
, 2025, 'Australian Gonococcal Surveillance Programme Annual Report, 2023', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.007
, 2025, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.017
, 2025, 'Australian Gonococcal Surveillance Program, 1 January to 31 March 2025', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.046
, 2025, 'Australian Gonococcal Surveillance Program, 1 April to 30 June 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.002
, 2025, 'Australian Gonococcal Surveillance Program, 1 January to 31 March 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.001
, 2025, 'Erratum: Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2024', Communicable Diseases Intelligence 2018, 49, http://dx.doi.org/10.33321/cdi.2025.49.008
, 2025, 'Neisseria meningitidis Serogroup Y Sequence Type 1466 and Urogenital Infections', Emerging Infectious Diseases, 31, pp. 86 - 93, http://dx.doi.org/10.3201/eid3101.240940
, 2025, 'Epidemiology of early-onset and late-onset invasive infections in Australian neonates and infants: a retrospective multicentre study', BMJ Public Health, 3, pp. e002733, http://dx.doi.org/10.1136/bmjph-2025-002733
, 2024, 'Australian Meningococcal Surveillance Programme Annual Report, 2023', Communicable Diseases Intelligence 2018, 48, http://dx.doi.org/10.33321/cdi.2024.48.52